BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
19.75
+0.18 (0.91%)
Feb 17, 2026, 12:54 PM EST - Market open

BioAge Labs Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22
825208--
Enterprise Value
527-117--
Last Close Price
19.575.79--
PB Ratio
2.530.64--
P/TBV Ratio
2.940.64--
Debt / Equity Ratio
0.030.03-1.310.12
Net Debt / Equity Ratio
-1.04-1.07-0.78-1.25
Net Debt / EBITDA Ratio
3.234.43-0.650.63
Net Debt / FCF Ratio
4.886.66-0.840.69
Quick Ratio
11.6912.760.374.72
Current Ratio
11.8712.860.444.78
Return on Equity (ROE)
-25.64%-50.35%--
Return on Assets (ROA)
-17.46%-25.44%-111.31%-
Return on Capital Employed (ROCE)
-32.00%-23.70%150.10%-177.10%
Earnings Yield
-9.29%-34.26%--
FCF Yield
-7.25%-25.00%--
Buyback Yield / Dilution
-1576.12%-541.23%-0.06%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q